Two new FDA PDUFA Dates!

Priority review for $BMY 's NIVO/IPI for the treatment of NSCLC. PDUFA Date of 8/6/2020.

PDUFA date of 11-24-2020 for $LQDA 's treprostinil for the treatment of pulmonary hypertension.

#stocks #money 

Full PDUFA Calendar at https://t.co/AYPe695BYY